ArticleSuicide & life-threatening behavior2022
Suicide exposure experience screener for use in therapeutic settings: A validation report.
Article in Suicide & life-threatening behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 11 citations in OpenAlex.
- A Randomized Controlled Trial of an SMS-Based Brief Contact Intervention for People Bereaved by Suicide.Suicide & life-threatening behavior · 2025Trial
- Lifetime Exposure to Suicide and Current Use of Suicide Prevention Competencies Among Catholic Clergy in Nigeria: A Multidimensional Structural Analysis.Journal of religion and health · 2026Article
- Understanding the Impact of Exposure to Different Types of Suicidal Thoughts and Behaviors.AJPM focus · 2026Article
- Exploring the Impact of the Caring Contacts Intervention on the Stress and Distress of Veterans and Service Members: Protocol for a Randomized Controlled Trial.JMIR research protocols · 2025Article
- Psychological Distress Among Suicide Exposed and Subsequently Bereaved Carers.International journal of mental health nursing · 2025Article
- Social Determinants and Developmental Factors Influencing Suicide Risk and Self-Injury in Healthcare Contexts.International journal of environmental research and public health · 2025Article
- Suicide exposure experience screener for use in therapeutic settings: A validation report.Suicide & life-threatening behavior · 2022Article
- Growth and Hope after loss: How TAPS facilitates posttraumatic growth in those grieving military deaths.Frontiers in psychology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 6 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionA brief screener assessing experience of exposure to suicide for use in therapeutic settings is warranted. To examine the concurrent validity of such a screening tool, labeled as the Suicide Exposure Experience Screener (SEES), the associations of the two SEES items: (i) reported closeness with the person who died by suicide and (ii) perceived impact of suicide death with psychological distress are presented.
methodsFive separate datasets comprising surveys from Australia, Canada, and the United States (N
resultsOverall, closeness and impact were significantly correlated with measures of global distress across five different datasets, showing small to medium effect sizes. Closeness and impact were also intercorrelated demonstrating a large effect size across all surveys. This report used cross-sectional data and comprised varied sample sizes across different datasets that influenced statistical significance of obtained effects and did not tease apart the roles of cumulative exposure of suicide and prolonged bereavement in experiencing global distress.
conclusionThe SEES has clinical utility in determining psychological distress in bereaved individuals and is recommended for use in therapeutic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.